`Inter Partes Review ofUSP 5,665,772
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In re Inter Partes Review of:
`U.S. Patent No. 5,665,772
`Issued: Sep. 9, 1997
`Application No.: 08/416,673
`Filing Date: Apr. 7, 1995
`
`)
`)
`)
`)
`)
`
`For: 0-alkylated rapamycin derivatives and their use, particularly as
`immunosuppressants
`
`FILED VIA PRPS
`
`PETITIONER'S POWER OF ATTORNEY FOR
`PETITION FOR INTER PARTES REVIEW
`OF U.S. PATENT NO. 5,665,772
`
`
`
`Petitioner Par Pharmaceutical, Inc.
`Inter Partes Review ofUSP 5,665,772
`PETITIONER'S POWER OF ATTORNEY
`
`Petitioner Par Pharmaceutical, Inc. appoints the following Practitioners
`
`associated with Customer Number 117694 as its attorneys to transact all business
`
`before the Patent Trial and Appeal Board of the United States Patent and
`
`Trademark Office in connection with the above-captioned Petition for Inter Partes
`
`Review of U.S. Patent No. 5,665,772.
`
`LEAD COUNSEL
`Daniel Brown (Reg. No. 54,005)
`Daniel.Brown@lw.com
`
`BACK-UP COUNSEL
`Robert Steinberg (Reg. No. 33,144)
`Bob.Steinberg@lw.com
`
`Postal & Hand-Delivery Address:
`Latham & Watkins LLP
`885 Third Avenue
`New York, NY 10022
`T: 212-906-1200
`F: 212-751-4864
`
`Postal & Hand-Delivery Address:
`Latham & Watkins LLP
`355 South Grand Avenue
`Los Angeles, CA 90071-1560
`T: 213-485-1234
`F: 213-891-8763
`
`The individual signing below has the authority to execute this document on
`
`behalf of Par Pharmaceutical, Inc.
`
`Name:
`
`Signature:
`
`Title:
`
`Telephone:
`
`Date:
`
`/
`
`.
`
`~c;-Nt ott
`
`~
`
`f) f ;[ ~ c TO I[
`
`I P
`
`I